- Home
- HPE vs TEVA Comparison
HPE vs TEVA Comparison
Compare HPE & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPE
- TEVA
- Stock Information
- Founded
- HPE 1939
- TEVA 1901
- Country
- HPE United States
- TEVA Israel
- Employees
- HPE N/A
- TEVA N/A
- Industry
- HPE Retail: Computer Software & Peripheral Equipment
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- HPE Technology
- TEVA Health Care
- Exchange
- HPE Nasdaq
- TEVA Nasdaq
- Market Cap
- HPE 20.3B
- TEVA 18.4B
- IPO Year
- HPE N/A
- TEVA N/A
- Fundamental
- Price
- HPE $16.89
- TEVA $18.08
- Analyst Decision
- HPE Buy
- TEVA Strong Buy
- Analyst Count
- HPE 14
- TEVA 6
- Target Price
- HPE $21.64
- TEVA $24.33
- AVG Volume (30 Days)
- HPE 18.9M
- TEVA 12.8M
- Earning Date
- HPE 06-03-2025
- TEVA 05-07-2025
- Dividend Yield
- HPE 3.08%
- TEVA N/A
- EPS Growth
- HPE 43.20
- TEVA N/A
- EPS
- HPE 2.08
- TEVA N/A
- Revenue
- HPE $31,226,000,000.00
- TEVA $16,616,000,000.00
- Revenue This Year
- HPE $8.76
- TEVA $6.30
- Revenue Next Year
- HPE $5.43
- TEVA N/A
- P/E Ratio
- HPE $8.12
- TEVA N/A
- Revenue Growth
- HPE 11.20
- TEVA 3.82
- 52 Week Low
- HPE $11.97
- TEVA $12.47
- 52 Week High
- HPE $24.66
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- HPE 59.45
- TEVA 74.33
- Support Level
- HPE $16.18
- TEVA $14.17
- Resistance Level
- HPE $16.54
- TEVA $16.86
- Average True Range (ATR)
- HPE 0.45
- TEVA 0.59
- MACD
- HPE 0.20
- TEVA 0.44
- Stochastic Oscillator
- HPE 90.70
- TEVA 95.91
About HPE Hewlett Packard Enterprise Company
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company, and its portfolio enables hybrid clouds and hyperconverged infrastructure. It uses a primarily outsourced manufacturing model and employs 60,000 people worldwide.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.